Eagle Health Investments LP

**Eagle Health Investments LP** manages $455M across a concentrated portfolio of 30 positions, demonstrating a focused approach within the healthcare sector. The fund's top holdings include ARGX at $52.8M and BCLYF at $45.0M, signaling significant conviction in specific biopharma catalysts. Further allocations to NTRA ($42.0M) and IM8N ($36.7M) underscore a deep, actionable research mandate. This structure suggests an active, high-conviction strategy targeting near-term value inflection points in specialized medical science.

📌 Top Holdings